Alpha-2 agonists for attention-deficit/hyperactivity disorder in youth: a systematic review and meta-analysis of monotherapy and add-on trials to stimulant therapy.
about
Canadian guidelines on pharmacotherapy for disruptive and aggressive behaviour in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, or conduct disorderClinical utility of guanfacine extended release in the treatment of ADHD in children and adolescentsOld drug tipepidine as new hope for children with ADHDThe pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: protocol for a systematic review and network meta-analysis of randomized controlled trials.Potential of Oxytocin in the Treatment of SchizophreniaADHD and adolescent athletes.Optimizing treatments for nicotine dependence by increasing cognitive performance during withdrawal.Changing patterns of alpha agonist medication use in children and adolescents 2009-2011Desynchronization of Theta-Phase Gamma-Amplitude Coupling during a Mental Arithmetic Task in Children with Attention Deficit/Hyperactivity Disorder.The norepinephrine transporter in attention-deficit/hyperactivity disorder investigated with positron emission tomography.Guanfacine Extended Release: A New Pharmacological Treatment Option in Europe.A Randomized Clinical Trial of an Integrative Group Therapy for Children With Severe Mood Dysregulation.Impulsive Aggression as a Comorbidity of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.Attention-deficit hyperactivity disorder medication use: factors involved in prescribing, safety aspects and outcomes.Guanfacine extended release for the treatment of attention-deficit/hyperactivity disorder in children and adolescents.Guanfacine for the treatment of attention deficit hyperactivity disorder in children and adolescents.Acute and Long-Term Cardiovascular Effects of Stimulant, Guanfacine, and Combination Therapy for Attention-Deficit/Hyperactivity Disorder.Pharmacological treatment of attention-deficit/hyperactivity disorder: assessing outcomes.A Review of Oxytocin's Effects on the Positive, Negative, and Cognitive Domains of Schizophrenia.Use of Prazosin for Pediatric PTSD-Associated Nightmares and Sleep Disturbances: A Retrospective Chart Review.The safety of extended-release drug formulations for the treatment of ADHD.Combination Therapy with Zonisamide and Antiparkinson Drugs for Parkinson's Disease: A Meta-Analysis.Discontinuation of pharmacological treatment of children and adolescents with attention deficit hyperactivity disorder: meta-analysis of 63 studies enrolling 11,788 patients.Telepsychiatrists' Medication Treatment Strategies in the Children's Attention-Deficit/Hyperactivity Disorder Telemental Health Treatment Study.The behavioural response of mice lacking NK₁ receptors to guanfacine resembles its clinical profile in treatment of ADHD.Meta-analysis and moderator analysis: can the field develop further?Off-label Prescribing Trends for ADHD Medications in Very Young Children.Pediatric pharmacoepidemiology - safety and effectiveness of medicines for ADHD.Tourette syndrome and other chronic tic disorders: an update on clinical management.Treatment of Children and Adolescents with Attention Deficit Hyperactivity Disorder and/or Tourette's Disorder with Clonidine Extended Release.The preclinical discovery of lofexidine for the treatment of opiate addiction.Attention-Deficit/Hyperactivity Disorder.
P2860
Q28260681-FF51AE9A-ED3C-4B5A-8644-D97942F55FADQ28265059-C3048237-5F68-4CB2-8164-66017106198CQ29012639-BD44C553-7F2C-4FBF-893E-8E7ADAEA6C2AQ33165620-E0078B6C-9D60-41A6-8F34-443E7ACFA0E3Q33761384-81CA13A3-3E37-4132-A74A-287E34C2C623Q33764804-D65617A0-6425-4FFD-8BA2-EFD4F2EABAE7Q34870758-178E2645-133B-4BE2-9FEC-7D127668232FQ35641630-47053073-B4B7-4D88-B19E-185AD29865C2Q35940810-887847A6-CD68-4FFB-B5B4-B85936C02782Q36424492-532EAF0D-32CA-422B-929E-EF49A07A5C8FQ36446854-ADB3E608-2D23-4201-A2AD-B87B7BBAD9FAQ36610730-C70CAEC5-A1BE-435A-8B64-73859D4A1E41Q36654483-C66F5156-9673-4C59-90CC-3188925D5AE3Q37722786-8E547007-8003-472C-922C-15A8F4C367CCQ38225962-F48756E6-E600-4682-941A-454FB7E01A93Q38387691-579B8793-914A-43C6-A15D-4FEF17103206Q38389306-EDDCF65C-875A-4A63-84ED-AB9BF0B64BE8Q38537323-8AF56CDA-F04C-484F-8294-0E225E5343E8Q38593718-30891DB0-9A1B-426B-9BC5-F251B63BC293Q38654153-98F1948C-9D6A-4997-A4E0-675E27C8F8DFQ38732635-E2604E06-DDCE-4AF1-ABEA-3BB66BD17532Q38762146-A9B926B3-CFF6-404D-84E7-E2B6A3A63981Q39154027-87827B55-E674-4776-A5E7-0BE74E1B3F66Q41646489-AA77007A-3868-457F-8079-88FE485CB678Q42070708-DDAFD1AA-6D65-45EA-B24A-E8DD2B0DAF38Q42425327-DAF886FA-01FC-460A-9DE3-BD0089AB2A85Q47164989-79BB913D-A524-47C2-8BED-9BA4B97BEF48Q47677209-46CB00DE-A0ED-4D93-B809-7638A15A876FQ47926575-95CC5C7C-39A0-439B-8CF6-6509C8B3FE2CQ49255458-4A6FF80D-8EF8-4246-BAF5-9F8CA842C139Q52305660-BF08F132-3B45-4A51-AB7E-E999D7889DB5Q52695372-B3023C34-FE78-4A9D-856C-98F72C1F2F6E
P2860
Alpha-2 agonists for attention-deficit/hyperactivity disorder in youth: a systematic review and meta-analysis of monotherapy and add-on trials to stimulant therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Alpha-2 agonists for attention ...... n trials to stimulant therapy.
@en
type
label
Alpha-2 agonists for attention ...... n trials to stimulant therapy.
@en
prefLabel
Alpha-2 agonists for attention ...... n trials to stimulant therapy.
@en
P2093
P1476
Alpha-2 agonists for attention ...... n trials to stimulant therapy.
@en
P2093
Christoph U Correll
Shimon Schwartz
Tomoya Hirota
P304
P356
10.1016/J.JAAC.2013.11.009
P577
2013-12-06T00:00:00Z